Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.560
+0.080 (2.30%)
Jan 21, 2026, 2:55 PM EST - Market open
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $137.4 million as of January 21, 2026. Its market cap has decreased by -51.16% in one year.
Market Cap
137.40M
Enterprise Value
39.58M
1-Year Change
-51.16%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $137.40M, a decrease of -71.85%. That is a compound annual growth rate of -24.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 134.31M | 17.97% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inogen | 168.59M |
| Lucid Diagnostics | 166.60M |
| Treace Medical Concepts | 165.35M |
| Apyx Medical | 159.19M |
| CVRx, Inc. | 146.51M |
| LENSAR | 143.33M |
| Picard Medical | 137.82M |
| Neuronetics | 132.52M |